Your browser doesn't support javascript.
loading
Tofacitinib Is an Effective Treatment for Refractory Scleromyositis Associated With Anti-PM/Scl.
Álvarez Troncoso, Jorge; Nuño González, Almudena; Martínez Robles, Elena; Sorriguieta Torre, Raquel; Robles Marhuenda, Ángel.
Affiliation
  • Álvarez Troncoso J; Internal Medicine, Systemic Autoimmune Diseases Unit, Hospital Universitario La Paz, Madrid, ESP.
  • Nuño González A; Dermatology Department, Hospital Universitario La Paz, Madrid, ESP.
  • Martínez Robles E; Internal Medicine, Systemic Autoimmune Diseases Unit, Hospital Universitario La Paz, Madrid, ESP.
  • Sorriguieta Torre R; Internal Medicine, Systemic Autoimmune Diseases Unit, Hospital Universitario La Paz, Madrid, ESP.
  • Robles Marhuenda Á; Internal Medicine, Systemic Autoimmune Diseases Unit, Hospital Universitario La Paz, Madrid, ESP.
Cureus ; 15(1): e34125, 2023 Jan.
Article in En | MEDLINE | ID: mdl-36843820
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Cureus Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Cureus Year: 2023 Document type: Article Country of publication: